Mage Biologics Inc.
PrivateLast Round
Corporate Funding
Jul 20, 2023
Total Funding Raised
$28M
Company Overview
Mage Biologics Inc. is a biotechnology company that develops orally administered monoclonal antibodies for the treatment of inflammatory bowel diseases such as ulcerative colitis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mage Biologics Inc. Comparables
Compare Mage Biologics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorriso Therapeutics | 84% | |
| Cyclo Therapeutics Inc | 74% | |
| Bristol Myers Squibb | 72% | |
Mage Biologics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 20, 2023 |
Mage Biologics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TVM Capital | Corporate Funding |
Mage Biologics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mage Biologics Inc.'s valuation, stock price, and market status.